Question 69

Errors associated with Topamax may be appropriately reported to ISMP MERP.

Errors related to Topamax, a medication used for epilepsy and migraine prevention, can be reported to ISMP MERP for analysis and prevention strategies. This is crucial as medication errors can significantly impact patient safety and treatment efficacy.

A) Varivax

Varivax is a varicella (chickenpox) vaccine, and while vaccine-related errors are important, they typically fall under different reporting systems related to immunization errors, not specifically ISMP MERP, which focuses more on medication errors rather than vaccines.

B) M-M-R II

M-M-R II is a measles, mumps, and rubella vaccine. Similar to Varivax, errors associated with this vaccine would be reported through vaccine-specific channels rather than ISMP MERP, which is dedicated to addressing medication errors.

C) Gardasil 9

Gardasil 9 is a vaccine for human papillomavirus (HPV). Errors related to vaccinations like Gardasil 9 are not typically reported to ISMP MERP, as the organization primarily focuses on medication errors associated with prescription and over-the-counter drugs.

D) Topamax

Topamax is a prescription medication that can be associated with various medication errors, including dosage errors and adverse reactions. These errors are appropriate for reporting to ISMP MERP, which is specifically designed to handle such cases to improve patient safety.

Conclusion

Reporting errors associated with Topamax to ISMP MERP is vital for enhancing medication safety practices. Unlike the other options, which pertain to vaccines and are reported through different systems, Topamax is a medication where its associated errors can have significant implications for patient outcomes, making it the correct choice for this reporting mechanism.